Delivery Order SPE2DR25D3504-SPE2DR26F7BF2
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) valued at $11,211.06. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among all eligible vendors....
- The Defense Logistics Agency awarded a delivery order valued at $29,710.91 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a quantity of 90 units. The contract was competitively awarded without set-aside designation under a firm fixed price arrangement, with an ultimate completion date of November 4, 2025. The award was issued on November 3, 2025, and the pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-25 mg tablets (90-count supply) on November 26, 2025, with completion scheduled for November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under a competitive...
- The Defense Logistics Agency awarded a $3,388.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 80-12.5 mg tablets (90-count supply) with an ultimate completion date of November 3, 2025. This non-set-aside competitive award was issued on October 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets in a quantity of 90 units, with a ceiling value of $2,731.15. This non-competitive delivery order, which is scheduled for completion by October 30, 2025, was placed under a firm fixed-price contract structure. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.42 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 80-12.5 mg tablets in quantities of 90, with delivery to conclude by December 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $23,124.56 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery under the company's existing federal supply framework. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $101.7K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count units), with completion scheduled for September 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is sourced from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a tactical procurement action under the company's broader relationship...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BF2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,282.30 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply) on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical supply vehicle enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/23/25 |